Sana Biotechnology, Inc.
SANA
$1.76
-$0.01-0.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.28M | 14.05M | 16.44M | 16.27M | 20.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.86M | 61.53M | 52.74M | 105.34M | 77.16M |
| Operating Income | -51.86M | -61.53M | -52.74M | -105.34M | -77.16M |
| Income Before Tax | -49.07M | -59.92M | -50.29M | -107.48M | -88.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.07M | -59.92M | -50.29M | -107.48M | -88.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.07M | -59.92M | -50.29M | -107.48M | -88.12M |
| EBIT | -51.86M | -61.53M | -52.74M | -105.34M | -77.16M |
| EBITDA | -48.06M | -57.47M | -48.85M | -101.59M | -72.91M |
| EPS Basic | -0.21 | -0.25 | -0.21 | -0.49 | -0.45 |
| Normalized Basic EPS | -0.12 | -0.16 | -0.14 | -0.29 | -0.24 |
| EPS Diluted | -0.21 | -0.25 | -0.21 | -0.49 | -0.45 |
| Normalized Diluted EPS | -0.12 | -0.16 | -0.14 | -0.29 | -0.24 |
| Average Basic Shares Outstanding | 236.30M | 235.41M | 234.44M | 217.29M | 197.32M |
| Average Diluted Shares Outstanding | 236.30M | 235.41M | 234.44M | 217.29M | 197.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |